November 20, 2015 / 2:41 PM / in 2 years

BUZZ-Aptose Biosciences Inc: FDA puts cancer drug trial on hold

** Drug developer’s U.S listed shares slump as much as 36 pct to a 2-year low of $3.41

** Stock, down 32 pct, was on track for its worst day in three years

** Aptose says FDA put its early-stage trial on a cancer drug on hold after a review found a malfunctioning infusion pump at a clinical site where the tests were being held

** Company expects delays in the trial but says review finding does not undermine the positive safety profile of the drug

** Up to Thursday’s close, the U.S.-listed stock had fallen 10 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below